Summit Therapeutics plc (‘Summit’ or the ‘Company’)Summit Announces Publication of Phase 2 Clinical Analyses of Gut Microbiome HealthOxford, UK, and Cambridge, […]
– World-renowned retina specialist to lead EYP-1901 development efforts and support expansion of EyePoint’s ocular disease pipeline –WATERTOWN, Mass., July […]
Research to Develop Live Replicating Vaccine (TNX-2300) to Protect Against COVID-19 Based on Bovine Parainfluenza VirusTNX-2300 Will Be Tonix’s Second […]